Horizon Pharma | HZNP - Selling And Administration Expenses

Horizon Pharma reported $372.53M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.21B 4M
ALKERMES ALKS:US USD 157.54M 4.76M
Amgen AMGN:US USD 1.47B 181M
AstraZeneca AZN:LN USD 3.53B 174M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Cara Therapeutics CARA:US USD 6.4M 484K
Coherus Biosciences CHRS:US USD 53.62M 8.79M
Eli Lilly And LLY:US USD 1.64B 29M
Endo International Ordinary Shares ENDP:US USD 192.46M 10.92M
Horizon Pharma HZNP:US USD 372.53M 25.03M
JAZZ PHA JAZZ:US USD 383.2M 65.52M
Merk MRK:US USD 2.63B 134M
Novartis NOVN:VX USD 3.7B 295M
Pacira Pharmaceuticals PCRX:US USD 63.97M 2.69M
Perrigo Ordinary Shares PRGO:US USD 308.6M 27.6M
Pfizer PFE:US USD 4.87B 1.33B
Prestige Brands PBH:US USD 56.96M 13.3M
Revance Therapeutics RVNC:US USD 63.54M 548K
Supernus Pharmaceuticals SUPN:US USD 73.97M 38.34M
Takeda 4502:JP JPY 262.3B 13.57B
Teva Pharmaceutical Industries TEVA:US USD 837M 60M
Valeant Pharmaceuticals VRX:CN USD 666M 5M
Xeris Pharmaceuticals Inc XERS:US USD 34.36M 34K
Zoetis ZTS:US USD 514M 13M